中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2014年
6期
521-523
,共3页
陆开智%袁玮%甘慧%孟志云%窦桂芳
陸開智%袁瑋%甘慧%孟誌雲%竇桂芳
륙개지%원위%감혜%맹지운%두계방
乙烷硒啉%电感耦合等离子体质谱法%血药浓度%药代动力学
乙烷硒啉%電感耦閤等離子體質譜法%血藥濃度%藥代動力學
을완서람%전감우합등리자체질보법%혈약농도%약대동역학
ethaselen%ICP -MS%plasma concentration%pharmacoki-netic
目的:建立湿法消解-电感耦合等离子体质谱法(ICP-MS)测定人血浆中乙烷硒啉的浓度,并将其用于乙烷硒啉分散片的人体药代动力学研究。方法血浆样品经硝酸消解后,用ICP-MS法测定给药后血浆中不同时间含硒药物总量,并用WinNonlin 5.2软件计算主要药代动力学参数。结果乙烷硒啉主要药代动力学参数如下:tmax为(9.20±0.98)h,Cmax为(597.58±221.73)ng· mL-1,AUC0-t为(2.57±0.92)μg· mL-1· h,平均滞留时间( MRT)为(24.60±0.63) h。结论建立的ICP-MS法简便、快速、灵敏,适用乙烷硒啉分散片临床监测。
目的:建立濕法消解-電感耦閤等離子體質譜法(ICP-MS)測定人血漿中乙烷硒啉的濃度,併將其用于乙烷硒啉分散片的人體藥代動力學研究。方法血漿樣品經硝痠消解後,用ICP-MS法測定給藥後血漿中不同時間含硒藥物總量,併用WinNonlin 5.2軟件計算主要藥代動力學參數。結果乙烷硒啉主要藥代動力學參數如下:tmax為(9.20±0.98)h,Cmax為(597.58±221.73)ng· mL-1,AUC0-t為(2.57±0.92)μg· mL-1· h,平均滯留時間( MRT)為(24.60±0.63) h。結論建立的ICP-MS法簡便、快速、靈敏,適用乙烷硒啉分散片臨床鑑測。
목적:건립습법소해-전감우합등리자체질보법(ICP-MS)측정인혈장중을완서람적농도,병장기용우을완서람분산편적인체약대동역학연구。방법혈장양품경초산소해후,용ICP-MS법측정급약후혈장중불동시간함서약물총량,병용WinNonlin 5.2연건계산주요약대동역학삼수。결과을완서람주요약대동역학삼수여하:tmax위(9.20±0.98)h,Cmax위(597.58±221.73)ng· mL-1,AUC0-t위(2.57±0.92)μg· mL-1· h,평균체류시간( MRT)위(24.60±0.63) h。결론건립적ICP-MS법간편、쾌속、령민,괄용을완서람분산편림상감측。
Objective To establish inductively coupled plasma mass spectrometry ( ICP -MS ) method for determining the concentration of ethaselen in human plasma , and to apply it to the pharmacokinetic study of ethaselen dispersible tablets.Methods Plasma samples were digested with nitric acid , then detected by ICP -MS method.The main pharmaco-kinetic parameters were calculated with non -compartmental analysis by Wi-nNonlin 5.2 software.Results The parameters pharmacokinetic results of ethaselen were as follows: tmax was ( 9.20 ± 0.98 ) h, Cmax was (597.58 ±221.73) ng· mL-1, AUC0-t was (2.57 ±0.92) ng· h· mL-1, the mean residence time (MRT) was (24.60 ±0.63)h.Conclusion The ICP-MS method is simple, rapid and sensitive, which is suitable for clini-cal determination of the concentration of ethaselen dispersible tablets in hu-man plasma.